V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009824 | 190008004 | 1.66 | 21.6 | null | 2020-08-10 | 2020-08-21 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 101041721 |
| 190009865 | 190008005 | 0 | 57.5 | null | 2021-08-20 | 2021-08-20 | OST Euramos 1 Closed Trial - A | 02 | N | OST A | 100326896 |
| 190009878 | 190008006 | 1.53 | 71.1 | Palliative (P) | null | 2020-12-31 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | IFOSFAMIDE | 100482626 |
| 190009897 | 190008007 | 1.77 | 67.2 | Adjuvant (A) | null | 2020-01-06 | CISPLATIN + GEMCITABINE | 02 | N | METHOTREXATE HIGH DOSE | 101513878 |
| 190009910 | 190008008 | 0 | 37 | Palliative (P) | null | 2016-05-27 | METHOTREXATE | 02 | N | METHOTREXATE | 101791109 |
| 190009917 | 190008009 | 1.88 | 66 | Curative (C) | 2021-08-09 | 2022-01-06 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 100316004 |
| 190009950 | 190008010 | 0 | 51.9 | Palliative (P) | 2020-05-28 | 2020-06-03 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 100607227 |
| 190010002 | 190008011 | 1.82 | 100.8 | Palliative (P) | 2020-04-21 | 2020-04-24 | Paclitaxel 7 day | 02 | N | EW EUROEWING 2012 ARM B VDC/IE | 100064157 |
| 190010035 | 190008012 | 1.67 | null | Curative (C) | 2020-09-13 | 2021-02-09 | GEMCITABINE + NAB PACLITAXEL | 02 | null | EW EUROEWING 2012 ARM A VAI | 101667228 |
| 190010044 | 190008013 | 0 | 21.6 | Neo-adjuvant (N) | 2022-03-25 | 2022-04-04 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 101484428 |
| 190010091 | 190008014 | 1.67 | 21.6 | Palliative (P) | 2020-12-06 | 2021-01-24 | MAP | 02 | Y | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101727589 |
| 190010093 | 190008015 | null | 77 | Curative (C) | 2021-09-16 | 2022-05-06 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | DOCETAXEL + GEMCITABINE | 101125124 |
| 190010117 | 190008016 | 1.51 | 56.7 | null | 2021-09-25 | 2021-09-25 | METHOTREXATE | 02 | N | METHOTREXATE | 100494715 |
| 190010122 | 190008017 | 1.73 | 11 | null | 2019-05-05 | 2019-05-09 | null | 02 | N | EW REL REECUR GEMCITABINE/DOCETAXEL | 100562215 |
| 190010126 | 190008018 | 0 | 51.1 | null | 2019-09-25 | 2020-11-19 | Methotrexate High Dose (3g/m2) | null | null | METHOTREXATE | 100810176 |
| 190010150 | 190008019 | 1.77 | 72 | null | 2019-05-20 | 2019-05-21 | GemCarbo Days 1+8 | 02 | N | NB HRNBL-1 COJEC IND COURSE C | 100080628 |
| 190010254 | 190008020 | 1.77 | 78.9 | Palliative (P) | 2018-05-19 | 2018-06-07 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101655316 |
| 190010259 | 190008021 | 1.57 | null | Curative (C) | 2020-04-27 | 2020-05-01 | Methotrexate High Dose (3g/m2) | 02 | N | METHOTREXATE | 101864734 |
| 190010298 | 190008022 | 0 | 57.2 | Adjuvant (A) | 2018-10-15 | 2018-10-16 | DOXORUBICIN | null | null | DOXORUBICIN | 101616146 |
| 190010347 | 190008023 | 0 | 27.5 | null | 2017-01-21 | 2017-05-29 | NIVOLUMAB | null | null | PEMBROLIZUMAB | 100457965 |
| 190010358 | 190008024 | 1.73 | 36.1 | null | 2020-03-13 | 2020-08-14 | OST Mifamurtide | Y | N | NIVOLUMAB | 100958431 |
| 190010360 | 190008025 | 0.78 | 62 | Palliative (P) | 2019-11-16 | 2020-03-08 | OST Euramos 1 Closed Trial - M | null | null | OST M | 100086863 |
| 190010414 | 190008026 | 1.62 | 59.2 | null | null | 2017-08-12 | Doxorubin 50mg/m2 | null | null | DOXORUBICIN | 100303566 |
| 190010459 | 190008027 | 0 | 62 | Palliative (P) | 2020-05-15 | 2020-05-18 | EW EuroEwing 2012 Arm B IE | Y | N | EW EUROEWING 2012 ARM B IE | 101317669 |
| 190010473 | 190008028 | 1.88 | 32.8 | Palliative (P) | 2021-06-11 | 2021-07-02 | Oxaliplatin + Modified de Gramont | 2 | null | EURO-EWING | 100010762 |
| 190010500 | 190008029 | 1.64 | 84.1 | Curative (C) | 2020-11-13 | 2020-11-13 | Capecitabine + Oxaliplatin 21day | 02 | N | NOT MATCHED | 101662835 |
| 190010523 | 190008030 | 0 | 40.9 | null | 2016-06-09 | 2016-10-09 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100632183 |
| 190010554 | 190008031 | 1.67 | 100 | null | 2020-03-12 | 2020-03-18 | EW EuroEwing 2012 Arm B VC | 01 | null | EW EUROEWING 2012 ARM B VC | 101448429 |
| 190010589 | 190008032 | 0 | 49 | Curative (C) | 2016-09-22 | 2017-04-04 | EURAMOS TRIAL | null | null | EW EUROEWING 2012 ARM A VAI | 100945629 |
| 190010596 | 190008033 | 1.59 | 13.2 | null | 2020-06-10 | 2020-09-02 | OST Rel Ifosfamide Etoposide | 01 | N | DHAP | 100167309 |
| 190010621 | 190008034 | 0 | 47 | Palliative (P) | 2016-05-20 | 2016-10-08 | DOXORUBICIN | null | Y | DOXORUBICIN | 100869513 |
| 190010631 | 190008035 | 1.74 | 54.6 | Curative (C) | 2021-03-26 | 2021-04-19 | NB HRNBL-1 COJEC Ind COURSE B | 02 | null | METHOTREXATE HIGH DOSE | 101376355 |
| 190010650 | 190008036 | 1.7 | 54 | Palliative (P) | 2018-11-03 | 2018-11-09 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 100561190 |
| 190010677 | 190008037 | null | 60.7 | Curative (C) | null | 2019-08-01 | EW EuroEwing 2012 Arm A VAI | 02 | N | MAP | 101071807 |
| 190010685 | 190008038 | 0 | 41.6 | Curative (C) | 2022-03-05 | 2022-03-05 | OST Euramos 1 Closed Trial - M | 01 | N | OST M | 101159852 |
| 190010719 | 190008039 | 0 | 42.5 | Neo-adjuvant (N) | 2019-02-12 | 2019-02-26 | ETOPOSIDE + IFOSFAMIDE | 02 | Y | ETOPOSIDE + IFOSFAMIDE | 100144097 |
| 190010739 | 190008040 | 0 | 34 | Curative (C) | 2018-09-07 | 2018-09-14 | Cyclophosphamide High Dose | 01 | null | NB BEACON TEMOZOLOMIDE AND TOPOTECAN | 100569513 |
| 190010755 | 190008041 | 0 | 57.4 | 03 | 2019-02-15 | 2019-03-02 | Methotrexate High Dose (3g/m2) | null | Y | METHOTREXATE | 101847115 |
| 190010800 | 190008042 | 1.86 | 59.8 | Curative (C) | 2017-03-27 | 2017-08-08 | Trial Unspecified | 02 | N | ETOPOSIDE | 100086834 |
| 190010837 | 190008043 | 1.66 | 89 | Adjuvant (A) | 2019-11-02 | 2019-11-09 | METHOTREXATE | 02 | Y | METHOTREXATE | 101586453 |
| 190010853 | 190008044 | 1.64 | 10.3 | Curative (C) | 2019-12-16 | 2020-08-04 | Etoposide + Ifosfamide (3 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100377460 |
| 190010859 | 190008045 | 1.77 | 91.3 | Palliative (P) | 2021-01-02 | 2021-01-26 | CARBO + THIOTEPA + TOPOTECAN | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100146635 |
| 190010928 | 190008046 | 1.74 | 88.8 | Palliative (P) | 2020-09-04 | 2022-02-06 | CAPECITABINE + OXALIPLATIN | 02 | null | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 101391675 |
| 190000680 | 190008047 | 1.82 | 32.5 | null | 2017-05-27 | 2017-05-27 | Docetaxel + Gemcitabine (prior RT) | 01 | null | DOCETAXEL + GEMCITABINE | 101671483 |
| 190000808 | 190008048 | null | 69.6 | Curative (C) | 2021-12-23 | 2021-12-29 | BUSULFAN + MELPHALAN | 02 | null | STS RHABDO VIT0910 VINC IRINO TEMOZ | 101186648 |
| 190002742 | 190008049 | 1.72 | 81.5 | Curative (C) | 2019-01-18 | 2019-09-25 | METHOTREXATE | 02 | N | METHOTREXATE | 100678585 |
| 190004163 | 190008050 | 1.55 | 98.4 | null | 2017-03-19 | 2017-04-15 | LANREOTIDE | 02 | N | TRIAL | 101625605 |
| 190006089 | 190008051 | 1.28 | 36 | Adjuvant (A) | 2018-04-01 | 2018-05-01 | Cisplatin + Paclitaxel | 02 | null | DOXORUBICIN + OLARATUMAB | 100145043 |
| 190007060 | 190008052 | 0 | 52.7 | Adjuvant (A) | 2020-02-15 | 2020-09-19 | OST Euramos 1 Closed Trial - A | null | null | OST A | 100854380 |
| 190007094 | 190008053 | 1.73 | null | Palliative (P) | null | 2020-11-02 | OST Euramos 1 Closed Trial - M | 02 | N | TRIAL | 101125341 |